Form 8-K Emergent BioSolutions For: Aug 06

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to Form 8-K Emergent BioSolutions For: Aug 06

Emergent BioSolutions (EBS) Tops Q2 EPS by 18c

August 6, 2015 9:19 AM EDT

Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of $0.36, $0.18 better than the analyst estimate of $0.18. Revenue for the quarter came in at $126.1 million versus the consensus estimate of $114.25 million.

Emergent BioSolutions reaffirmed FY2015 guidance.

For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.

... More

Emergent BioSolutions (EBS) to Spin Biosciences Business Unit into Separate, Publicly-Traded Company

August 6, 2015 7:28 AM EDT

Emergent BioSolutions (NYSE: EBS) announced that its Board of Directors has authorized management to pursue a tax-free spin-off of the company's Biosciences business into a separate, stand-alone publicly-traded company. The spin-off is expected to create two independent public companies with distinct strategic plans, growth strategies, and operational and development priorities.

The new Biosciences company, to be named at a later date, will focus on providing novel oncology and hematology therapeutics to meaningfully improve patients' lives. The core technology of the Biosciences company will be its ADAPTIR platform applied to immuno-oncology. Emergent BioSolutions... More